hydrazine has been researched along with Aggressive Natural Killer Cell Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvert, V; Feith, DJ; Fox, T; Hengst, J; LeBlanc, FR; Liu, X; Loughran, TP; Petricoin, EF; Yun, J | 1 |
1 other study(ies) available for hydrazine and Aggressive Natural Killer Cell Leukemia
| Article | Year |
|---|---|
Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Survival; Enzyme Inhibitors; G2 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Hydrazines; Janus Kinases; JNK Mitogen-Activated Protein Kinases; Leukemia, Large Granular Lymphocytic; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Signal Transduction; Sphingolipids; STAT Transcription Factors | 2015 |